News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
836,238 Results
Type
Article (85896)
Company Profile (649)
Press Release (749693)
Section
Business (232139)
Career Advice (4122)
Deals (39700)
Drug Delivery (124)
Drug Development (90751)
Employer Resources (196)
FDA (17974)
Job Trends (17302)
News (395410)
Policy (39632)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2984)
Academic (1)
Accelerated approval (3)
Adcomms (26)
Allergies (75)
Alliances (56596)
ALS (71)
Alzheimer's disease (1423)
Antibody-drug conjugate (ADC) (117)
Approvals (17957)
Artificial intelligence (201)
Autoimmune disease (14)
Automation (11)
Bankruptcy (400)
Best Places to Work (12529)
BIOSECURE Act (21)
Biosimilars (107)
Biotechnology (447)
Bladder cancer (52)
Brain cancer (25)
Breast cancer (210)
Cancer (1694)
Cardiovascular disease (120)
Career advice (3524)
Career pathing (32)
CAR-T (142)
Cell therapy (405)
Cervical cancer (15)
Clinical research (72469)
Collaboration (687)
Compensation (354)
Complete response letters (27)
COVID-19 (2820)
CRISPR (39)
C-suite (182)
Cystic fibrosis (97)
Data (1569)
Decentralized trials (2)
Denatured (41)
Depression (36)
Diabetes (176)
Diagnostics (6719)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (104)
Drug pricing (90)
Drug shortages (18)
Duchenne muscular dystrophy (71)
Earnings (94886)
Editorial (32)
Employer branding (25)
Employer resources (167)
Events (127739)
Executive appointments (554)
FDA (18817)
Featured Employer (65)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (577)
Gene editing (90)
Generative AI (21)
Gene therapy (285)
GLP-1 (710)
Government (5069)
Grass and pollen (3)
Guidances (33)
Healthcare (20732)
Huntington's disease (24)
IgA nephropathy (22)
Immunology and inflammation (100)
Indications (23)
Infectious disease (2919)
Inflammatory bowel disease (142)
Inflation Reduction Act (11)
Influenza (37)
Intellectual property (67)
Interviews (811)
IPO (17674)
IRA (38)
Job creations (5183)
Job search strategy (2860)
Kidney cancer (10)
Labor market (32)
Layoffs (516)
Leadership (18)
Legal (10044)
Liver cancer (70)
Lung cancer (247)
Lymphoma (115)
Machine learning (2)
Management (65)
Manufacturing (245)
MASH (58)
Medical device (14309)
Medtech (14314)
Mergers & acquisitions (22214)
Metabolic disorders (548)
Multiple sclerosis (61)
NASH (22)
Neurodegenerative disease (78)
Neuropsychiatric disorders (23)
Neuroscience (1858)
NextGen: Class of 2025 (7663)
Non-profit (5055)
Northern California (2026)
Now hiring (37)
Obesity (300)
Opinion (263)
Ovarian cancer (58)
Pain (60)
Pancreatic cancer (56)
Parkinson's disease (118)
Partnered (15)
Patents (157)
Patient recruitment (79)
Peanut (47)
People (64682)
Pharmaceutical (132)
Pharmacy benefit managers (13)
Phase I (22363)
Phase II (31490)
Phase III (23715)
Pipeline (778)
Podcasts (116)
Policy (105)
Postmarket research (3542)
Preclinical (10019)
Press Release (72)
Prostate cancer (76)
Psychedelics (34)
Radiopharmaceuticals (247)
Rare diseases (332)
Real estate (7376)
Recruiting (75)
Regulatory (26287)
Reports (53)
Research institute (2643)
Resumes & cover letters (649)
Rett syndrome (3)
RNA editing (2)
RSV (31)
Schizophrenia (65)
Series A (113)
Series B (64)
Service/supplier (25)
Sickle cell disease (43)
Southern California (1733)
Special edition (18)
Sponsored (33)
Startups (4279)
State (2)
Stomach cancer (11)
Supply chain (44)
The Weekly (74)
United States (17854)
Vaccines (698)
Venture capitalists (33)
Webinars (13)
Weight loss (223)
Women's health (33)
Worklife (17)
Date
Today (96)
Last 7 days (507)
Last 30 days (2556)
Last 365 days (31809)
2025 (5463)
2024 (34453)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Alabama (49)
Alaska (7)
Arizona (231)
Arkansas (8)
Asia (49665)
Australia (8772)
California (4638)
Canada (1468)
China (408)
Colorado (166)
Connecticut (198)
Delaware (108)
Europe (113684)
Florida (586)
Georgia (126)
Hawaii (1)
Idaho (64)
Illinois (425)
India (21)
Indiana (250)
Iowa (7)
Japan (111)
Kansas (106)
Kentucky (17)
Louisiana (8)
Maine (58)
Maryland (765)
Massachusetts (3726)
Michigan (174)
Minnesota (298)
Mississippi (1)
Missouri (52)
Montana (24)
Nebraska (26)
Nevada (50)
New Hampshire (52)
New Jersey (1343)
New Mexico (26)
New York (1316)
North Carolina (949)
North Dakota (7)
Northern California (2026)
Ohio (154)
Oklahoma (12)
Oregon (43)
Pennsylvania (989)
Puerto Rico (6)
Rhode Island (19)
South America (1646)
South Carolina (3)
South Dakota (1)
Southern California (1733)
Tennessee (40)
Texas (623)
Utah (111)
Virginia (86)
Washington D.C. (37)
Washington State (471)
West Virginia (2)
Wisconsin (37)
836,238 Results for "pivot bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
February 10, 2025
·
4 min read
Press Releases
Pivot Bio Launches New Retail Distribution Partnerships
December 18, 2024
·
3 min read
Press Releases
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
February 27, 2025
·
5 min read
Press Releases
Pivot Bio Appoints Melih Keyman to Board of Directors
December 3, 2024
·
3 min read
Press Releases
Peer-Reviewed Study Validates Pivot Bio’s Gene-Edited Microbes as a Third Source of Nitrogen Delivery
January 19, 2025
·
5 min read
Press Releases
Pivot Bio Names Jason Hoag Head of North American Commercial Distribution
November 20, 2024
·
2 min read
Press Releases
BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
March 10, 2025
·
12 min read
Press Releases
BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
March 12, 2025
·
10 min read
Duchenne muscular dystrophy
Regenxbio Gears Up to Challenge Sarepta in DMD as Gene Therapy Advances to Pivotal Studies
Regenxbio is pushing its Duchenne muscular dystrophy gene therapy into pivotal development, with a BLA planned for 2026—potentially posing a threat to Sarepta’s Elevidys.
November 19, 2024
·
2 min read
·
Tristan Manalac
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
1 of 83,624
Next
